$VERU
Veru Inc
PRICE
$1 βΌ-0.99%
Extented Hours
VOLUME
561,606
DAY RANGE
0.92 - 1.01
52 WEEK
0.6606 - 6.57
Join Discuss about VERU with like-minded investors
@soheil.n #StockTraders.NET
cool...wasn't even on the radar > @singletary said: $VERU killer unwind
143 Replies 11 π 14 π₯
Key Metrics
Market Cap
91.18 M
Beta
0
Avg. Volume
650.96 K
Shares Outstanding
90.28 M
Yield
0%
Public Float
0
Next Earnings Date
2023-12-07
Next Dividend Date
Company Information
the female health company/veru healthcare is a therapeutics company focused on developing and commercializing pharmaceuticals and devices in menβs and womenβs health and oncology. to realize this goal, veru healthcare has three divisions: pharmaceutical and devices, consumer health products, and public sector. for men, product and product candidates are in the areas of benign prostatic hyperplasia, male infertility, amelioration of side effects of hormonal prostate cancer therapies, prostate cancer, gout, and sexual dysfunction. womenβs health has product candidates for female sexual health and advanced breast and ovarian cancers and markets fc2, a disposable contraceptive device, to ob gyn physicians and is the only female condom approved by fda that offers dual protection against sexually transmitted infections, including hiv/aids and the zika virus, and unintended pregnancy. since the female health company began distributing fc2 in 2007, the product has been shipped to 144 countries
CEO: Mitchell Steiner
Website: https://verupharma.com/
HQ: 48 NW 25th St Ste 102 Miami, 33127-4442 Florida
Related News